| Product Name | Vadimezan - API |
| Product Code | DA-V072-a |
| Chemical name | Vadimezan |
| Synonyms | 2-(5,6-Dimethyl-9-oxo-9H-xanthen-4-yl)acetic Acid; 5,6-Dimethyl-9-oxo-9H-xanthen-4-ylacetic Acid; 5,6-Dimethylxanthenone-4-acetic Acid; AS 1404; ASA 404; DMXAA; 5,6-Dimethyl-9-oxo-9H-xanthene-4-acetic Acid; |
| Impurity | NA |
| CAS Number | 117570-53-3 |
| Alternate CAS # | NA |
| Molecular form | C17H14O4 |
| Appearance | Off-White Solid |
| Melting Point | NA |
| Mol. Weight | 282.29 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | impurities,metabolites,pharmaceutical standards,intermediates,Fine Chemicals |
| Boiling Point | NA |
| Applications | Vadimezan is a drug that displayed vascular-disrupting activity and induced haemorrhagic necrosis and tumour regression in pre-clinical animal models. It is a substrate for the immune adaptor protein STING in mice. |
| Dangerous Goods Info | NA |
| References | |
| Extra Notes | |
| Documents (MSDS) | No Data Available |
| Keywords |
